SAM
Sectoral Asset Management Portfolio holdings
AUM
$125M
1-Year Est. Return
68.15%
This Fund
S&P 500
1 Year Est. Return
+68.15%
AUM
$125M
AUM Growth
-$37.3M
(-23%)
Holding
88
Top Buys
| 1 | +$11.1M | |
| 2 | +$1.24M | |
| 3 | +$989K | |
| 4 |
Cogent Biosciences
COGT
|
+$919K |
| 5 |
Amgen
AMGN
|
+$866K |
Top Sells
| 1 | +$8.08M | |
| 2 | +$7.55M | |
| 3 | +$6.35M | |
| 4 |
AnaptysBio
ANAB
|
+$5.96M |
| 5 |
Immatics
IMTX
|
+$5.02M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVMN
1
Evommune Inc
EVMN
$763M
| $10.1M | 8.08% |
+589,005
|
|
||
|
CTNM
2
Contineum Therapeutics
CTNM
$499M
| $9.15M | 7.34% |
800,787
|
|
||
3
Eli Lilly
LLY
$866B
| $7.82M | 6.27% |
7,276
-2,100
|
|
||
|
SI
4
Shoulder Innovations Inc
SI
$272M
| $7.04M | 5.64% |
492,435
+62,153
|
|
||
5
UnitedHealth
UNH
$261B
| $4.49M | 3.6% |
13,595
+50
|
|
||
|
6
Amgen
AMGN
$196B
| $4.28M | 3.43% |
13,070
+2,730
|
|
||
7
Johnson & Johnson
JNJ
$570B
| $4.2M | 3.37% |
20,300
+5,000
|
|
||
8
AbbVie
ABBV
$404B
| $3.84M | 3.08% |
16,800
+2,000
|
|
||
9
Vertex Pharmaceuticals
VRTX
$118B
| $3.63M | 2.91% |
8,005
+290
|
|
||
10
Abbott
ABT
$193B
| $2.94M | 2.36% |
23,498
+6,300
|
|
||
11
Regeneron Pharmaceuticals
REGN
$80.6B
| $2.87M | 2.3% |
3,715
-253
|
|
||
12
Intuitive Surgical
ISRG
$175B
| $2.75M | 2.2% |
4,850
-900
|
|
||
13
Boston Scientific
BSX
$106B
| $2.63M | 2.11% |
27,626
+5,500
|
|
||
14
argenx
ARGX
$44.8B
| $2.43M | 1.95% |
2,894
-996
|
|
||
15
Danaher
DHR
$143B
| $2.42M | 1.94% |
10,575
|
|
||
16
Stryker
SYK
$142B
| $2.3M | 1.85% |
6,550
+2,250
|
|
||
17
Thermo Fisher Scientific
TMO
$193B
| $2.26M | 1.81% |
3,900
|
|
||
18
Merck
MRK
$283B
| $2.25M | 1.81% |
21,400
+5,000
|
|
||
19
Gilead Sciences
GILD
$178B
| $2.2M | 1.76% |
17,885
-1,665
|
|
||
20
Insmed
INSM
$31.2B
| $1.95M | 1.56% |
11,182
-2,243
|
|
||
21
DexCom
DXCM
$27.4B
| $1.9M | 1.53% |
28,700
+8,000
|
|
||
22
Vera Therapeutics
VERA
$2.77B
| $1.87M | 1.5% |
36,858
+6,670
|
|
||
23
Structure Therapeutics
GPCR
$4.2B
| $1.66M | 1.33% |
23,872
-198,000
|
|
||
24
BioNTech
BNTX
$25B
| $1.64M | 1.31% |
17,218
-442
|
|
||
25
Edwards Lifesciences
EW
$48.8B
| $1.47M | 1.18% |
17,250
+2,250
|
|